MedTrace Logo

Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy

NCT04535895 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-10-12

No results posted yet for this study

Summary

Adjuvant radiotherapy after breast conserving surgery has been shown to improve both local control and overall survival. Dose escalation of the tumor bed by addition of a boost after whole breast radiotherapy reduces the risk of local recurrence in invasive breast cancer.

Simultaneous integrated boost (SIB) techniques have been shown to provide more conformal treatment plans than conventional sequential boost, in addition, SIB enables a reduction in the overall treatment time by 1 week compared to conventional boost techniques.

The proposed study is aimed at evaluating radiation-induced toxicity in patients treated with breast-conserving surgery in combination with radiotherapy using SIB technique.

Conditions

Interventions

RADIATION

Simultaneous integrated boost

Adjuvant breast cancer irradiation including simultaneous integrated boost

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Tanja Langsenlehner, MD · Medical University of Graz, Dept. of Therapeutic Radiology and Oncology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-16
Primary Completion
2022-08-31
Completion
2025-08-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04535895 on ClinicalTrials.gov